HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, J. Articles by Lyman, W. D. Search for Related Content PubMed PubMed Citation Articles by Zhao, J. Articles by Lyman, W. D.

An Efficient Method for the Cryopreservation of Fetal Human Liver Hematopoeitic Progenitor Cells

^a Children's Research Center of Michigan; Departments of
^b Pediatrics and
^c Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA

Key Words. Cryopreservation • Fetal human liver • Hematopoietic progenitor cells • Stem cells

Jiun Zhao, M.D., 3901 Beaubien, Detroit, Michigan 48201, USA. Telephone: 313-745-2400; Fax: 313-745-0282.

The use of human hematopoietic progenitor cells (HPC) for transplantation requires efficient recovery methods and cryopreservation procedures. The purpose of this study was to determine cryopreservation techniques for fetal human liver (FHL) CD34⁺ cells. We assessed FHL HPC recovery efficiency after freezing and thawing by viability testing, fluorescence-activated cell sorting analysis, and colony-forming ability under different conditions. We also determined optimal cell freezing concentrations and the effect of rate-controlled freezing on cell recovery. Lastly, cell recovery after varying freezing time periods was examined. Our results indicated that optimal cell recovery occurs when: A) cryopreservation medium consists of either 5% dimethylsulphoxide (DMSO) or 10% DMSO in combination with either 20% fetal bovine serum (FBS) or 70% FBS and when Iscove's modified Dulbecco's medium consists of not more than 10% DMSO; B) a rate-controlled freezing device container is used; C) CD34⁺ cells are frozen at a concentration of 1 x 10⁶/ml, and D) a thawing temperature of 37°C is used. These observations indicate that cryopreservation of FHL HPC is possible for up to 18 months in optimal conditions without losing hematopoietic activity.

This article has been cited by other articles:

				J. H. Moon, J. R. Lee, B. C. Jee, C. S. Suh, S. H. Kim, H. J. Lim, and H. K. Kim Successful vitrification of human amnion-derived mesenchymal stem cells Hum. Reprod., August 1, 2008; 23(8): 1760 - 1770. [Abstract] [Full Text] [PDF]